442 related articles for article (PubMed ID: 28603178)
1. Role of Adipokines in Cardiovascular Disease.
Lau WB; Ohashi K; Wang Y; Ogawa H; Murohara T; Ma XL; Ouchi N
Circ J; 2017 Jun; 81(7):920-928. PubMed ID: 28603178
[TBL] [Abstract][Full Text] [Related]
2. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
4. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
Jaganathan R; Ravindran R; Dhanasekaran S
Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
[TBL] [Abstract][Full Text] [Related]
6. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
Jung UJ; Choi MS
Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
[TBL] [Abstract][Full Text] [Related]
7. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
[TBL] [Abstract][Full Text] [Related]
8. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
Rajesh Y; Sarkar D
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
10. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
Lafontan M
Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
[TBL] [Abstract][Full Text] [Related]
11. Adipokines as drug targets in diabetes and underlying disturbances.
Andrade-Oliveira V; Câmara NO; Moraes-Vieira PM
J Diabetes Res; 2015; 2015():681612. PubMed ID: 25918733
[TBL] [Abstract][Full Text] [Related]
12. Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension.
Korolczuk A; Bełtowski J
Curr Pharm Des; 2017; 23(10):1533-1539. PubMed ID: 28120721
[TBL] [Abstract][Full Text] [Related]
13. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.
Blüher M; Mantzoros CS
Metabolism; 2015 Jan; 64(1):131-45. PubMed ID: 25497344
[TBL] [Abstract][Full Text] [Related]
14. The new adipose tissue and adipocytokines.
Bulcão C; Ferreira SR; Giuffrida FM; Ribeiro-Filho FF
Curr Diabetes Rev; 2006 Feb; 2(1):19-28. PubMed ID: 18220614
[TBL] [Abstract][Full Text] [Related]
15. [Hormones of adipose tissue in diabetes mellitus and its complications (review of literature and the authors'own data)].
Zak KP; Kondratskaia IN; Popova VV
Lik Sprava; 2010; (5-6):39-55. PubMed ID: 21488367
[TBL] [Abstract][Full Text] [Related]
16. Adipokines: a link between obesity and cardiovascular disease.
Nakamura K; Fuster JJ; Walsh K
J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
[TBL] [Abstract][Full Text] [Related]
17. Adipokine dysregulation and adipose tissue inflammation in human obesity.
Unamuno X; Gómez-Ambrosi J; Rodríguez A; Becerril S; Frühbeck G; Catalán V
Eur J Clin Invest; 2018 Sep; 48(9):e12997. PubMed ID: 29995306
[TBL] [Abstract][Full Text] [Related]
18. The adipose tissue as an endocrine organ.
Adamczak M; Wiecek A
Semin Nephrol; 2013 Jan; 33(1):2-13. PubMed ID: 23374889
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism.
Rodríguez A; Ezquerro S; Méndez-Giménez L; Becerril S; Frühbeck G
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E691-714. PubMed ID: 26330344
[TBL] [Abstract][Full Text] [Related]
20. The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus.
Liang W; Ye DD
Cytokine Growth Factor Rev; 2019 Aug; 48():32-39. PubMed ID: 31229411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
